期刊文献+

辛伐他汀对慢性阻塞性肺疾病大鼠MMP-1 MMP-9及抗基质金属蛋白酶-1表达的影响 被引量:2

下载PDF
导出
摘要 慢性阻塞性肺疾病(chronic obstructive pulmonary dis-ease,COPD)是一种以不完全可逆、呈进行性发展的气流受限为特征的疾病状态,气流受限与长期吸烟及其他有害颗粒或有害气体所致的肺部慢性炎症有关[1]。大量研究表明,他汀类药物可抑制肺部慢性炎症,从而降低COPD患者的发病率和病死率。本实验采用气道内滴注脂多糖(LPS)加被动吸烟法制备COPD大鼠模型[2],通过早期辛伐他汀干预,
出处 《中国药物与临床》 CAS 2012年第4期450-451,共2页 Chinese Remedies & Clinics
  • 相关文献

参考文献11

二级参考文献65

  • 1李雯,徐永健,张珍祥.Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2005,25(2):151-154. 被引量:9
  • 2钟晓芃,朱宝玉.基质金属蛋白酶及组织型金属蛋白酶抑制物与慢性阻塞性肺疾病的关系[J].国外医学(呼吸系统分册),2005,25(6):455-457. 被引量:8
  • 3陈文彬.慢性阻塞性肺疾病[M]//朱元钰,陈文彬.呼吸病学.北京:人民卫生出版社,2003:877-891.
  • 4Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry[ J]. Circ Res,2003,92( 8 ) :827-839.
  • 5Massova I, Kotra L P, Fridman R,et al. Matrix metalloproteinases: structures, evolution, and diversification [ J ]. FASEB J, 1998,12 ( 12 ) : 1075-1095.
  • 6Shapiro S D. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease [ J]. Am J Respir Crit Care Med, 1994, 150 (2) :160.
  • 7Vernooy J H ,Lindeman J H ,Jacobs J A,et al. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD [ J ].Chest,2004,126(6):1802-1810.
  • 8Russell R E, Thorley A, Culpitt S V, et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases [ J ]. Am J Physiol Lung Cell Mol Physiol, 2002,283 ( 4 ) : 867.
  • 9Aviles B, Belda J, Margarit G, et al. Markers of airway remodeling in induced sputum from healthy smokers [ J ]. Arch Bronconeumol,2006,42 ( 5 ) :235-240.
  • 10Imai K, Dalal S S, Chen E S, et al. Human collagenase ( matrix metalloproteinase-1 ) expression in the lungs of patients with emphysema[J]. Am J Respir Crit Care Med,2001,163 (3Pt1) :786-791.

共引文献294

同被引文献38

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8229
  • 2Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med, 2007,176:753-760.
  • 3Dobler CC, Wong KK, Marks GB. Associations between statins and COPD :a systematic review. BMC Puhn Med,2009,9:32.
  • 4Cazzola M, Ciaprini C, Page CP et at. Targeting systemic inflammation : novel therapies for the treatment of chronic obstructive pulmonary disease. Expert Opin Ther Targets, 2007, 11 : 1273-1286.
  • 5Gudmundsson G, Ulrik CS, Gislason T, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Puimon Dis, 2012,7:571-576.
  • 6Lee JH, Lee DS, Kim EK, et al. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med, 2005,172:987-993.
  • 7Bellosta S, Via D, Canavesi M, et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol, 1998,18 : 1671-1678.
  • 8Kim SE, Thanh Thny TT, Lee JH, et at. Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophagcs exposed to cigarette smoke extract. Exp Mol Med,2009,41:277- 287.
  • 9Nath N, Ciri S, Prasad R, et al. Potential targets of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol, 2004,172 : 1273-1286.
  • 10Mancini GB, Etminan M, Zhang B, et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitor, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coil Cardiol, 2006,47:2554- 2560.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部